Is Ocugen Stock a “Buy” Right Now?
Ocugen Inc (Nasdaq: OCGN) recently saw a gain of over 800%. So what happens now?
Compass Therapeutics IPO Set for $50 Million Nasdaq Offering
The Compass Therapeutics IPO is set to raise $50 million on November 13. But is Compass Therapeutics stock a good investment opportunity?